表紙:乾癬性関節炎治療の世界市場:2022年
市場調査レポート
商品コード
1062969

乾癬性関節炎治療の世界市場:2022年

Psoriatic Arthritis Treatment Global Market Report 2022

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 400 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
乾癬性関節炎治療の世界市場:2022年
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 400 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の乾癬性関節炎治療市場について調査し、市場の特性、規模と成長、地域・国別動向、競合情勢、市場シェア、市場動向と戦略を網羅しています。また、セグメント別の市場の実績と予測、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 乾癬性関節炎治療市場の特徴

第3章 乾癬性関節炎治療市場の動向と戦略

第4章 乾癬性関節炎の治療に対するCOVID-19の影響

第5章 乾癬性関節炎治療の市場規模と成長

  • 世界の乾癬性関節炎治療の市場実績、2016年~2021年、10億米ドル
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の乾癬性関節炎治療の市場予測、2021年~2026年、2031年、10億米ドル
    • 市場の促進要因
    • 市場の抑制要因

第6章 乾癬性関節炎治療市場のセグメンテーション

  • 世界の乾癬性関節炎治療市場、薬剤クラス別セグメンテーション、実績および予測、2016年~2021年、2021年~2026年、2031年、10億米ドル
  • 非ステロイド性抗炎症薬(NSAID)
  • 疾患修飾性抗リウマチ薬(DMARD)
  • 生物製剤
  • その他
  • 世界の乾癬性関節炎治療市場、投与経路別セグメンテーション、実績および予測、2016年~2021年、2021年~2026年、2031年、10億米ドル
  • 経口
  • 非経口
  • 局所
  • 世界の乾癬性関節炎治療市場、流通チャネル別セグメンテーション、実績および予測、2016年~2021年、2021年~2026年、2031年、10億米ドル
  • 院内薬局
  • 小売薬局
  • オンライン薬局

第7章 乾癬性関節炎治療市場の地域別および国別の分析

  • 世界の乾癬性関節炎治療市場、地域別、実績および予測、2016年~2021年、2021年~2026年、2031年、10億米ドル
  • 世界の乾癬性関節炎治療市場、国別、実績および予測、2016年~2021年、2021年~2026年、2031年、10億米ドル

第8章 アジア太平洋の乾癬性関節炎治療市場

第9章 中国の乾癬性関節炎治療市場

第10章 インドの乾癬性関節炎治療市場

第11章 日本の乾癬性関節炎治療市場

第12章 オーストラリアの乾癬性関節炎治療市場

第13章 インドネシアの乾癬性関節炎治療市場

第14章 韓国の乾癬性関節炎治療市場

第15章 西欧の乾癬性関節炎治療市場

第16章 英国の乾癬性関節炎治療市場

第17章 ドイツの乾癬性関節炎治療市場

第18章 フランスの乾癬性関節炎治療市場

第19章 東欧の乾癬性関節炎治療市場

第20章 ロシアの乾癬性関節炎治療市場

第21章 北米の乾癬性関節炎治療市場

第22章 米国の乾癬性関節炎治療市場

第23章 南米の乾癬性関節炎治療市場

第24章 ブラジルの乾癬性関節炎治療市場

第25章 中東の乾癬性関節炎治療市場

第26章 アフリカの乾癬性関節炎治療市場

第27章 乾癬性関節炎治療市場の競合情勢と企業プロファイル

  • 乾癬性関節炎治療市場の競合情勢
  • 乾癬性関節炎治療市場の企業プロファイル
    • Amgen
    • Johnson & Johnson
    • Bristol-Myers Squibb Company
    • Celgene Corporation
    • Novartis

第28章 乾癬性関節炎治療パイプライン分析

第29章 乾癬性関節炎治療市場における主要な合併と買収

第30章 乾癬性関節炎治療市場の将来展望と潜在性分析

第31章 付録

目次
Product Code: h1191

“Psoriatic Arthritis Treatment Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global psoriatic arthritis treatment market.

This report focuses on psoriatic arthritis treatment market which is experiencing strong growth. The report gives a guide to the psoriatic arthritis treatment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the psoriatic arthritis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Psoriatic Arthritis Treatment market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider psoriatic arthritis treatment market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The psoriatic arthritis treatment market section of the report gives context. It compares the psoriatic arthritis treatment market with other segments of the psoriatic arthritis treatment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, psoriatic arthritis treatment indicators comparison.

Scope

Markets Covered:

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biologics; Others

2) By Route Of Administration: Oral; Parenteral; Topical

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Amgen; Johnson & Johnson; Bristol-Myers Squibb Company; Celgene Corporation; Novartis

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Psoriatic Arthritis Treatment Market Characteristics

3. Psoriatic Arthritis Treatment Market Trends And Strategies

4. Impact Of COVID-19 On Psoriatic Arthritis Treatment

5. Psoriatic Arthritis Treatment Market Size And Growth

  • 5.1. Global Psoriatic Arthritis Treatment Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Psoriatic Arthritis Treatment Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Psoriatic Arthritis Treatment Market Segmentation

  • 6.1. Global Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Disease-modifying anti-rheumatic drugs (DMARDs)
  • Biologics
  • Others
  • 6.2. Global Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Parenteral
  • Topical
  • 6.3. Global Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Psoriatic Arthritis Treatment Market Regional And Country Analysis

  • 7.1. Global Psoriatic Arthritis Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Psoriatic Arthritis Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Psoriatic Arthritis Treatment Market

  • 8.1. Asia-Pacific Psoriatic Arthritis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Psoriatic Arthritis Treatment Market

  • 9.1. China Psoriatic Arthritis Treatment Market Overview
  • 9.2. China Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Psoriatic Arthritis Treatment Market

  • 10.1. India Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Psoriatic Arthritis Treatment Market

  • 11.1. Japan Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Psoriatic Arthritis Treatment Market

  • 12.1. Australia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Psoriatic Arthritis Treatment Market

  • 13.1. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Psoriatic Arthritis Treatment Market

  • 14.1. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Psoriatic Arthritis Treatment Market

  • 15.1. Western Europe Psoriatic Arthritis Treatment Market Overview
  • 15.2. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Psoriatic Arthritis Treatment Market

  • 16.1. UK Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Psoriatic Arthritis Treatment Market

  • 17.1. Germany Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Psoriatic Arthritis Treatment Market

  • 18.4. France Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.5. France Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Psoriatic Arthritis Treatment Market

  • 19.1. Eastern Europe Psoriatic Arthritis Treatment Market Overview
  • 19.2. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Psoriatic Arthritis Treatment Market

  • 20.1. Russia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Psoriatic Arthritis Treatment Market

  • 21.1. North America Psoriatic Arthritis Treatment Market Overview
  • 21.2. North America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Psoriatic Arthritis Treatment Market

  • 22.1. USA Psoriatic Arthritis Treatment Market Overview
  • 22.2. USA Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Psoriatic Arthritis Treatment Market

  • 23.1. South America Psoriatic Arthritis Treatment Market Overview
  • 23.2. South America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Psoriatic Arthritis Treatment Market

  • 24.1. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Psoriatic Arthritis Treatment Market

  • 25.1. Middle East Psoriatic Arthritis Treatment Market Overview
  • 25.2. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Psoriatic Arthritis Treatment Market

  • 26.1. Africa Psoriatic Arthritis Treatment Market Overview
  • 26.2. Africa Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Psoriatic Arthritis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Psoriatic Arthritis Treatment Market Competitive Landscape And Company Profiles

  • 27.1. Psoriatic Arthritis Treatment Market Competitive Landscape
  • 27.2. Psoriatic Arthritis Treatment Market Company Profiles
    • 27.2.1. Amgen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Johnson & Johnson
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Bristol-Myers Squibb Company
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Celgene Corporation
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Novartis
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Psoriatic Arthritis Treatment Pipeline Analysis

29. Key Mergers And Acquisitions In The Psoriatic Arthritis Treatment Market

30. Psoriatic Arthritis Treatment Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer